213 related articles for article (PubMed ID: 20587365)
1. Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia.
Jaworski F; Dubertret C; Adès J; Gorwood P
Psychiatry Res; 2011 Jan; 185(1-2):129-34. PubMed ID: 20587365
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
Jabben N; Arts B; van Os J; Krabbendam L
J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
5. The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness.
Ringen PA; Melle I; Birkenaes AB; Engh JA; Faerden A; Vaskinn A; Friis S; Opjordsmoen S; Andreassen OA
Acta Psychiatr Scand; 2008 Oct; 118(4):297-304. PubMed ID: 18759810
[TBL] [Abstract][Full Text] [Related]
6. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
Ringen PA; Lagerberg TV; Birkenaes AB; Engn J; Faerden A; Jónsdottir H; Nesvåg R; Friis S; Opjordsmoen S; Larsen F; Melle I; Andreassen OA
Psychol Med; 2008 Sep; 38(9):1241-9. PubMed ID: 18070373
[TBL] [Abstract][Full Text] [Related]
7. Aggression and substance abuse in bipolar disorder.
Grunebaum MF; Galfalvy HC; Nichols CM; Caldeira NA; Sher L; Dervic K; Burke AK; Mann JJ; Oquendo MA
Bipolar Disord; 2006 Oct; 8(5 Pt 1):496-502. PubMed ID: 17042888
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
9. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
10. Substance use in severe mental illness: self-medication and vulnerability factors.
Bizzarri JV; Rucci P; Sbrana A; Miniati M; Raimondi F; Ravani L; Massei GJ; Milani F; Milianti M; Massei G; Gonnelli C; Cassano GB
Psychiatry Res; 2009 Jan; 165(1-2):88-95. PubMed ID: 19054572
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
[TBL] [Abstract][Full Text] [Related]
12. Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight.
Yen CF; Cheng CP; Huang CF; Ko CH; Yen JY; Chang YP; Chen CS
Bipolar Disord; 2009 Mar; 11(2):190-7. PubMed ID: 19267701
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
Simonsen C; Sundet K; Vaskinn A; Ueland T; Romm KL; Hellvin T; Melle I; Friis S; Andreassen OA
J Int Neuropsychol Soc; 2010 Sep; 16(5):771-83. PubMed ID: 20509984
[TBL] [Abstract][Full Text] [Related]
14. Bipolar disorder not otherwise specified in relation to the bipolar spectrum.
Bader CD; Dunner DL
Bipolar Disord; 2007 Dec; 9(8):860-7. PubMed ID: 18076535
[TBL] [Abstract][Full Text] [Related]
15. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
[TBL] [Abstract][Full Text] [Related]
16. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
17. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
Laursen TM; Agerbo E; Pedersen CB
J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
[TBL] [Abstract][Full Text] [Related]
18. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].
Dakhlaoui O; Essafi I; Haffani F
Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders.
Matthews AM; Huckans MS; Blackwell AD; Hauser P
Bipolar Disord; 2008 Mar; 10(2):266-70. PubMed ID: 18271905
[TBL] [Abstract][Full Text] [Related]
20. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Elbogen EB; Johnson SC
Arch Gen Psychiatry; 2009 Feb; 66(2):152-61. PubMed ID: 19188537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
